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Summary
 
The entry of B lymphocytes into secondary lymphoid organs is a critical step in the development
of an immune response, providing a site for repertoire shaping, antigen-induced activation and
selection. These events are controlled by signals generated through the B cell antigen receptor
(BCR) and are associated with changes in the migration properties of B cells in response to
chemokine gradients. The chemokine stromal cell–derived factor (SDF)-1
 
a
 
 is thought to be one
of the driving forces during those processes, as it is produced inside secondary lymphoid organs
and induces B lymphocyte migration that arrests upon BCR engagement. The signaling path-
way that mediates this arrest was genetically dissected using B cells deficient in specific BCR-
coupled signaling components. BCR-induced inhibition of SDF-1
 
a
 
 chemotaxis was depen-
dent on Syk, BLNK, Btk, and phospholipase C (Plc)
 
g
 
2 but independent of Ca
 
2
 
1
 
 mobilization,
suggesting that the target of BCR stimulation was a protein kinase C (PKC)-dependent sub-
strate. This target was identified as the SDF-1
 
a
 
 receptor, CXCR4, which undergoes PKC-
dependent internalization upon BCR stimulation. Mutation of the internalization motif SSXXIL
in the COOH terminus of CXCR4 resulted in B cells that constitutively expressed this receptor
upon BCR engagement. These studies suggest that one pathway by which BCR stimulation re-
sults in inhibition of SDF-1
 
a
 
 migration is through PKC-dependent downregulation of CXCR4.
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T
 
he ability to successfully mount an immune response
depends on the interaction of multiple cell types, in-
suring that autoreactivity is avoided, diversity and specific-
ity are achieved, and a memory of the encounter is estab-
lished. The anatomic compartmentalization of APCs, T and
B lymphocytes, and effector cells in secondary lymphoid
organs like the spleen or lymph node maximizes the proba-
bility of interaction of the cellular and humoral factors nec-
essary to achieve these responses. Zones containing specific
cellular populations allow ordered and sequential interac-
tions to take place, thereby insuring that only a small subset
of B lymphocytes are stimulated and produce antibody or
undergo further somatic hypermutation within germinal
centers (GCs)
 
1
 
 (1, 2). Although important during an immune
response, changes in the migration and position of B cells in-
side lymphoid organs are also intimately associated with their
stage of maturation. An antigen receptor (AgR)-dependent
positive selection process allows some of the newly gener-
ated bone marrow B cells to progress to the mature B cell
stage. This selection event is associated with follicular relo-
calization. In those sites, in contact with follicular dendritic
cells, B lymphocytes might receive survival signals and be-
come recruited to the long-lived B cell repertoire (3–5).
Above a threshold of AgR engagement, B cells migrate
toward or arrest within the periarteriolar lymphoid sheath,
where the probability of encountering Ag-specific T cells is
maximal. In the absence of cognate interactions with T
cells, activated B cells will die, and as a consequence, strong
autoreactivity will be purged from the repertoire (6, 7).
Rare activated B cells that receive cognate T cell help will
proliferate, and some of them will join follicles to form
GCs. The GC reaction generates B cells with new migra-
tion properties. Thus, plasmocytes can relocate into the red
pulp of the spleen, join the peripheral circulation, and enter
the bone marrow, where they will produce antibody for an
extended period of time (8). Memory B cells will either re-
 
1
 
Abbreviations used in this paper:
 
 BLR1, Burkitt’s lymphoma receptor 1;
GCs, germinal centers; HSA, human serum albumin; PKC, protein ki-
nase C; Plc, phospholipase C; wt, wild type. 
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circulate or reside in the marginal zone of the spleen, the
privileged area for reencounter with blood-borne antigen (1).
Four chemokines with the ability to direct the migration
of B lymphocytes are known to be expressed within second-
ary lymphoid organs. These are B lymphocyte chemoattrac-
tant (BLC) (or B cell–attracting chemokine [BCA]-1),
which binds to the Burkitt’s lymphoma receptor 1 (BLR1)
(or CXCR5) (9, 10); secondary lymphoid tissue chemokine
(SLC, or 6C-kine, exodus-2) and Epstein-Barr virus–
induced molecule 1 ligand chemokine (ELC, or MIP3
 
b
 
),
both binding to the chemokine receptor CCR7 (11, 12); and
SDF-1
 
a
 
 (or pre-B cell growth–stimulating factor [PBSF]),
which stimulates cells through CXCR4 (13, 14). The im-
portance of these chemokines in the migration and selection
processes is suggested either by the differential expression of
their receptors during B cell maturation or by the fact that
AgR engagement can modulate the associated chemotactic
responses. BLR1, the receptor for BLC, is only expressed
when cells mature from newly generated to follicular B cells;
this expression is likely to account, at least in part, for the
tropism of those cells for follicles. Thus, inactivation of
BLR1 by targeted gene disruption is associated with deficits
in spleen and Peyer’s patch follicles (15, 16). BCR activation
has a direct impact on B cell chemotaxis to ELC and SDF-
1
 
a
 
, resulting in either enhancement or arrest, respectively
(12, 14). Given that AgR signaling controls B cell matura-
tion and is associated with cell relocalization, the direct regu-
lation of chemokine responsiveness by BCR engagement is
likely to play a major role in driving the selection and orga-
nization of B lymphocytes within lymphoid organs.
The mechanism by which BCR ligation may lead to
SDF-1
 
a
 
 unresponsiveness has been addressed in this study
by using the genetically defined DT40 B cell system. Tar-
geted disruption of many of the signaling components of
the BCR-stimulated pathway have been generated in these
cells and have demonstrated great utility in defining the
mechanisms by which antigen stimulation of B cells results
in cellular activation. DT40 B cells migrate efficiently to
SDF-1
 
a
 
 and are arrested in their migration by BCR cross-
linking. Through the analysis of a series of signaling mu-
tants of DT40 cells, we have established that BCR stimula-
tion results in a calcium-independent, protein kinase C
(PKC)-dependent downregulation of the SDF-1
 
a
 
 receptor
CXCR4. These studies suggest mechanisms by which di-
verse signals may influence this pathway and thereby modu-
late redirected migration of B cells inside lymphoid tissues.
 
Materials and Methods
 
Reagents.
 
Human SDF-1
 
a
 
, 12G5 anti-CXCR4, and anti–
SDF-1
 
a
 
 antibodies were from R & D Systems, Inc.; human se-
rum albumin (HSA) and BSA, FITC-conjugated F(ab
 
9
 
)
 
2
 
 frag-
ment of goat anti–mouse IgG, and PMA were from Sigma
Chemical Co. The M4 mAb anti–chicken IgM has previously
been described (17).
 
DT40 Cell Culture and Transfections.
 
Wild type (wt) and Btk-
(18), Syk- (19), phospholipase C (Plc)
 
g
 
2- (20), BLNK- (21), or
IP3R (22)-deficient chicken DT40 cells were maintained in
RPMI 1640 supplemented with 10% FBS, 1% chicken serum,
50 mM 2-ME, 2 mM 
 
l
 
-glutamine, and antibiotics. The con-
structions containing wt and SSLKIL
 
®
 
AALKAA (4A) mutants
of human CXCR4 have been described previously (23). Cells
were transfected by electroporation at 250 V and 960 
 
m
 
F in PBS
(10
 
7
 
 cells/0.5 ml). 20 
 
m
 
g expression constructs were cotransfected
with 2 
 
m
 
g pBabe-puro
 
r
 
 vector (24). Transfectants were selected
in 0.5 
 
m
 
g/ml puromycin 24 h after electroporation. The presence
of CXCR4 surface expression was determined by FACS
 
®
 
 analysis
with 12G5 mAb and FITC-conjugated secondary antibody. In each
condition: DT40-wt 
 
1
 
 CXCR4 (wt or 4A), Plcg2
 
2
 
\
 
2
 
 
 
1
 
 CXCR4
(wt or 4A). Two clones were analyzed for the experiments; they
had comparable and homogenous levels of expression ranging
from 120 to 200 arbitrary units (data not shown).
 
Chemotaxis Assay.
 
DT40 cells (10
 
6
 
 cells per condition) were
washed and resuspended in 100 ml RPMI 1640 and 0.25% HSA
and incubated for 1 h at 39
 
8
 
C in the presence of different con-
centrations of anti-BCR antibodies. Cells were then added to the
top chamber of a 6.5-mm diameter, 5-
 
m
 
m pore polycarbonate
transwell culture insert (Costar Corp.); the lower chamber con-
tained RPMI 0.25% HSA alone or supplemented with 100 nM
SDF-1
 
a
 
. Migration proceeded for 3 h at 39
 
8
 
C. Transmigrated
cells were then vigorously suspended and counted with a FAC-
Scan™ (Becton Dickinson) for 20 s at 60 
 
m
 
l/min, with gating on
forward and side scatter to exclude debris. 100% migration was
obtained by counting cells added directly to the lower chamber.
 
CXCR4 Surface Expression Analysis.
 
Cells expressing wt or
the 4A mutant of human CXCR4 were resuspended in RPMI
1640 and 0.25% HSA at 10
 
7
 
 cells/ml. They were then diluted
twice with the same buffer or with medium supplemented with
200 nM SDF-1
 
a
 
, 200 nM PMA, or 20 
 
m
 
g/ml anti-BCR mAb
and kept either at 4
 
8
 
C (for 
 
T
 
 
 
5 
 
0) or incubated at 39
 
8
 
C for 1 or 2 h.
All subsequent steps were carried out at 4
 
8
 
C. Cells were washed
once in staining buffer (PBS, 0.5% BSA, 0.05% azide, and 5%
normal goat serum) and incubated in the presence of 12G5 anti-
CXCR4 antibodies for 1 h. After two washes, primary antibodies
were detected using a FITC-conjugated F(ab
 
9
 
)
 
2
 
 fragment of goat
anti–mouse IgG. Signals were acquired on a FACScan™. Results
are given as percentage of controls, 100% corresponding to cells
incubated in medium alone. No inhibition of 12G5 binding was
found when cells were preincubated with SDF-1
 
a
 
, PMA, or
anti-BCR at 4
 
8
 
C, showing that modulation of 12G5 binding was
the consequence of an active process. Further controls included
absence of staining of nontransfected cells by 12G5 mAb (data
not shown) or of CXCR4-transfected cells by an isotype control
primary antibody (Fig. 3 B).
 
Results
 
DT40 Cells Migrate in Response to SDF-1
 
a
 
 and Arrest upon
BCR Ligation.
 
To determine if the chicken B cell line
DT40 was an accurate model for SDF-1
 
a
 
–dependent mi-
gration and BCR-induced arrest, we characterized the abil-
ity of these cells to migrate in response to this chemokine.
DT40 cells were placed on the upper side of a transwell
apparatus, and human SDF-1
 
a
 
 was placed on the opposite
side. DT40 cells migrated efficiently (Fig. 1) to this che-
mokine. The migration was specifically inhibited by anti–
SDF-1
 
a
 
 antibody but not by an irrelevant antibody (not
shown), demonstrating the specificity of this migration ef-
fect. Cross-linking of the BCR on DT40 cells with the
murine mAb M4 for 1 h resulted in a dose-dependent inhi- 
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bition of SDF-1
 
a
 
–mediated migration, resulting in full in-
hibition at 5 
 
m
 
g/ml. The ability of this chicken cell line to
respond to the human chemokine further confirms that
SDF-1
 
a
 
 and its receptor are highly conserved among di-
verse species. Although the chicken version of SDF-1
 
a
 
 and
its receptor have not been characterized, it is likely that a
high degree of sequence conservation will be found for this
species as well.
 
BCR-induced Inhibition of SDF-1
 
a
 
 Migration Is Plc
 
g
 
-depen-
dent and Ca
 
2
 
1
 
-independent.
 
A series of homozygous cell
lines deficient in specific BCR signaling components has
been generated in DT40 cells (18–22). These mutant lines
were tested for their ability to migrate in response to SDF-1
 
a
 
and to arrest upon BCR cross-linking. As seen in Fig. 2, all
of the mutants tested, whether deficient in either early
(syk) or late (Btk, BLNK, Plc
 
g
 
2, IP
 
3
 
R) components of
BCR-induced signaling, migrated in response to SDF-1
 
a
 
.
In contrast, the BCR-induced arrest of SDF-1
 
a
 
–directed
migration was observed in some, but not all, of the mutants
tested. Although cells deficient for molecules involved in
Plc
 
g
 
2 activation such as syk, BLNK, Btk, and Plc
 
g
 
2 were
unable to mediate BCR-induced arrest of SDF-1 migra-
tion, IP
 
3
 
R-deficient cells (generated by deletion of the
three IP
 
3
 
 receptor genes) retained their ability to migrate in
response to SDF-1
 
a
 
 and arrest upon BCR cross-linking.
DT40 cells have three IP
 
3
 
 receptors that mediate the efflux
of calcium from intracellular stores in response to IP
 
3
 
 (22).
A triple knockout of these receptors is unable to trigger in-
tracellular calcium release in response to BCR-induced IP
 
3
 
stimulation yet maintains its ability to arrest SDF-1
 
a
 
–medi-
ated migration. IP
 
3
 
 and diacylglycerol are both produced in
response to Plc
 
g
 
2 activation. As BCR-induced arrest is
Plc
 
g
 
2 dependent but IP
 
3
 
R independent, it implies that the
pathway triggered by Plc
 
g
 
2, which is affected in BCR-
induced arrest of SDF-1
 
a
 
 migration, is diacylglycerol depen-
dent, which, in turn, activates PKC. Thus, the dependence
on Plc
 
g
 
2 in the absence of IP
 
3
 
-stimulated release of cal-
cium implies that the mechanism by which BCR cross-
linking results in migration arrest to SDF-1
 
a
 
 may be depen-
dent upon PKC activation through Plc
 
g
 
2.
 
CXCR4, the Receptor for SDF-1
 
a
 
, Is Downregulated by
BCR Cross-linking and PKC Activation.
 
One mechanism by
which BCR activation could lead to arrest of SDF-1
 
a
 
–
mediated migration might result from BCR-induced down-
regulation of the SDF-1
 
a
 
 receptor from the cell surface by
a PKC-dependent internalization of the SDF-1
 
a
 
 receptor.
Previous studies have demonstrated that the SDF-1 receptor,
CXCR4, is rapidly internalized upon activation of PKC by
phorbol esters that, in turn, can be blocked by inhibitors of
PKC (25, 26). To determine if a BCR-induced, PKC-
dependent internalization of the CXCR4 pathway is present
in DT40 cells, the human SDF-1
 
a
 
 receptor, CXCR4, was
stably transfected into wt and Plc
 
g
 
2-mutant DT40 cells.
Cell surface expression of human CXCR4 on DT40 cells is
downregulated in response to BCR cross-linking, phorbol
ester treatment, or SDF-1
 
a
 
 exposure (Fig. 3). However,
BCR-induced downregulation of CXCR4 is blocked in
the Plc
 
g
 
2-deficient DT40 background, which correlates
with the inability of this mutant to display BCR-mediated
arrest of SDF-1a migration. To determine if Plcg2 is up-
stream, downstream, or pleiotropic in relation to CXCR4,
this mutant was tested for its ability to respond to phorbol
esters or SDF-1a. CXCR4 surface expression is downreg-
ulated normally in Plcg2-deficient cells in response to
phorbol esters or SDF-1a (Fig. 3), indicating that Plcg2 lies
upstream of CXCR4 in the BCR-induced internalization
Figure 1. Migration of DT40 cells in response to SDF-1a and inhibition
by BCR engagement. DT40 cells (106 cells per condition) were kept un-
stimulated or stimulated with increasing concentrations of M4 anti-BCR
antibodies for 1 h. They were then assayed for migration in the presence or
absence of SDF-1a and blocking anti–SDF-1a mAb. Results are expressed
as the mean percentage of input cells that migrated into the lower chamber.
Error bars represent the SD of two independent experiments.
Figure 2. BCR-induced inhibition of migration is Plcg2 dependent
and calcium independent. Wt DT40 cells or subclones deficient for Btk,
Syk, BLNK, Plcg2, or for the three IP3 receptors (IP3R2/2/2) were as-
sayed for migration with or without preincubation with 10 mg/ml anti-
BCR antibodies and in the presence (SDF-1a) or absence (med) of 100
nM SDF-1a in the lower chamber. Results are depicted as in Fig. 1 and
represent the mean value of at least four independent experiments. Error
bars, SD.1464 B Cell Antigen Receptor–induced Internalization of CXCR4
pathway and that SDF-1a–induced internalization is inde-
pendent of Plcg2 activation. These results thus suggest that
the BCR-induced arrest of SDF-1a–directed migration
may be due in part to CXCR4 internalization triggered by
BCR-mediated stimulation of Plcg2 and PKC activation.
In addition, they show that SDF-1a and BCR activation
lead to CXCR4 surface downregulation through different
pathways in DT40 B cells.
The SSXXIL Motif in the COOH Terminus of CXCR4 Is
Required for BCR-induced Receptor Internalization. Signoret
et al. (23) have demonstrated that a SSXXIL motif, similar
to that required for endocytosis of CD4 and the TCR
complex, is required for phorbol ester–induced, but not
ligand-induced, internalization of CXCR4. To determine
the contribution of this motif to the BCR-induced inter-
nalization of CXCR4 in DT40 cells, we generated stable
transfectants of DT40 wt or Plcg2-mutant cells expressing
a CXCR4 mutant in which the SSLKIL sequence was re-
placed by AALKAA. As seen in Figs. 3 and 4, wt DT40
cells expressing the wt human CXCR4 receptor internalize
this receptor in response to BCR cross-linking, SDF-1a
treatment, and PMA stimulation. In contrast, the SSLKIL®
AALKAA mutant CXCR4 receptor (designated 4A in Fig.
4), whether expressed in wt or Plcg2-mutant DT40 cells,
was incapable of BCR- or PMA-induced internalization
(Fig. 4) but retained significant receptor downmodulation
in response to SDF-1a. The 4A mutant CXCR4 was un-
able to migrate in response to SDF-1a, either in the pres-
ence or absence of BCR cross-linking (data not shown).
The basis for this migration defect has not been determined.
BCR- and Plcg2-dependent internalization of CXCR4
thus appears to utilize the same pathway as PMA, a PKC-
dependent downmodulation of this receptor.
Discussion
AgR signaling determines B cell maturation, selection,
and orientation within lymphoid organs. Progression from
newly generated B cells into MZ and follicular B cells is
driven by BCR signaling and is associated with specific an-
atomic localization inside the spleen. Supra-threshold AgR
engagement redirects B cells from follicles, MZ, or blood
circulation toward the periarteriolar lymphoid sheath. De-
pending on their ability to direct cognate interaction with
T cells, a humoral response will emerge or B cells will die
in a few days (2, 5, 6, 27).
It is now clearly established that chemokines play an im-
portant role in these relocalization processes. Thus, the ex-
pression of BLR1 is associated with follicular B cell matu-
ration and is required for their tropism in the spleen and
Peyer’s patch, whereas SDF-1a and SLE responses are rap-
idly regulated upon BCR engagement (12, 14, 16). The
BCR-induced downregulation of CXCR4 demonstrated
here offers a first example in which differential AgR en-
gagement might promote differential responsiveness to a
Figure 3. BCR engagement induces a Plcg2-dependent internalization
of CXCR4. (A) Human CXCR4 expressing wt or Plcg2-deficient DT40
cells were incubated with medium alone or medium supplemented with
either 100 nM SDF-1a, 100 nM PMA, or 10 mg/ml anti-BCR mAb.
Cells were either transferred immediately on ice (T 5 0) or after incuba-
tion for 1 or 2 h at 398C (T 5 1, 2 h). They were then processed for
staining with 12G5 anti-CXCR4 mAb. Values represent the percentage
of staining, 100% corresponding to unstimulated cells processed in paral-
lel. They are the mean value of four experiments realized on two different
clones for each condition. Error bars, SD. (B)  Representative anti-
CXCR4 staining of human CXCR4 expressing wt or Plcg2-deficient
DT40 cells after 2 h of incubation in medium alone or medium supple-
mented with anti-BCR mAb, PMA, or SDF-1a. Control represents
staining of untreated cells using an isotype-matched, irrelevant mAb.
Figure 4. An SSXXIL internalization motif present in CXCR4 is re-
quired for its surface downregulation after BCR engagement. Wt or
Plcg2-deficient DT40 cells transfected with wt or 4A mutants of human
CXCR4 were kept unstimulated or incubated with either 100 nM SDF-1a,
100 nM PMA, or 10 mg/ml anti-BCR mAb for 2 h at 398C. They were
then stained for CXCR4 surface expression. Results represent the per-
centage of staining, 100% corresponding to cells incubated directly at
48C. Results represent the mean value of four experiments realized on
two different clones for each condition. Error bars, SD.1465 Guinamard et al.
chemokine and allow repertoire-based interclonal compe-
tition for migration toward a restricted, chemokine-secret-
ing environment (28). However, as seen in Fig. 3, BCR
cross-linking results in a twofold reduction in CXCR4 ex-
pression. Although this change in expression may account
for some of the migration inhibition seen, it suggests that
other pathways may be involved as well. The generation
of CXCR4 mutants that are deficient in BCR-induced
downregulation yet retain chemotactic response to SDF-1a
will allow further dissection of the contribution of this
pathway to the antigen-driven compartmentalization of
lymphocytes. In addition, the definition of SDF-1a secre-
tion sites will provide important clues toward the under-
standing of B cell migration and selection.
In vitro studies have shown that pro-B cells are depen-
dent on contact with stromal cells and cytokines for sur-
vival, whereas cells expressing the pre-B cell receptor are
only dependent on soluble factors (29, 30). Bone marrow
stromal cells produce SDF-1a, and pro-B cells respond to
this chemokine (13, 31). It is tempting to transpose our
data from the early steps of pro-B to pre-B cell transition.
Thus, like BCR, pre-BCR signaling might induce the
downregulation of CXCR4 and block SDF-1a–dependent
migration of pre-B cells toward stromal cells. Therefore,
CXCR4 downregulation might allow B cells to lose stro-
mal cell tropism upon successful rearrangement of their
IgH gene and signaling through the pre-B cell receptor.
This mechanism could guarantee the restriction of rare
niches to pro-B cells. In agreement with the importance of
SDF-1 during early B cell differentiation, SDF-1 and
CXCR4 knockout mice show a profound defect in pro-B
cell production (32–34). The present definition of a path-
way from BCR to the CXCR4 receptor and of a motif re-
sponsible for this coupling may allow the construction of
mutants to directly test the role of this pathway in vivo.
Such analysis might provide insights that will define how
Ag-dependent competitive migration participates in B cell
maturation and response to Ag.
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